StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $99 at RBC Capital
October 26, 2018 7:09 AM
RBC Capital analyst Kennen MacKay raised the price target on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
BioMarin Pharma (BMRN) Tops Q3 EPS by 15c, Offers Guidance
October 25, 2018 4:10 PM
BioMarin Announces Third Quarter 2018 Results
October 25, 2018 4:05 PM